Literature DB >> 25207118

Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report.

Ralitsa Robeva1, Dobromir Tanev2, Georgi Kirilov1, Milena Stoycheva3, Analia Tomova2, Philip Kumanov1, Rasho Rashkov2, Zlatimir Kolarov2.   

Abstract

BACKGROUND: The neuroendocrine system is known to influence immunity, but the precise interactions between different hormones and autoimmune disorders remain obscure. AIMS: The present study aimed to investigate the role of daily serum melatonin concentrations in the development of systemic lupus erythematosus (SLE) in women. STUDY
DESIGN: Case-control study.
METHODS: One-hundred and eleven SLE female patients and 46 healthy women were included in the study. Daily serum melatonin levels were investigated in all participants.
RESULTS: SLE patients showed significantly lower daily melatonin levels in comparison to healthy women during the short photoperiod (17.75±7.13 pg/mL [16.05] vs. 21.63±6.60 pg/mL [20.10], p=0.012). Hormone concentrations were inversely related to the SLE activity index (SLEDAI) (r= -0.268, p=0.004), but they did not correlate to any particular American College Rheumatology (ACR) criterion (p>0.05 for all).
CONCLUSION: Daily melatonin levels were decreased in women with systemic lupus erythematosus and correlated inversely to the activity of the autoimmune disease. Further studies are needed to clarify the importance of the pineal and extrapineal melatonin secretion in patients with systemic lupus erythematosus as well as the interrelations between hormones and autoimmunity.

Entities:  

Keywords:  Melatonin; SLEDAI; systemic lupus erythematosus; women

Year:  2013        PMID: 25207118      PMCID: PMC4115899          DOI: 10.5152/balkanmedj.2013.8064

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  26 in total

1.  Sex-dependent effect of melatonin on systemic erythematosus lupus developed in Mrl/Mpj-Faslpr mice: it ameliorates the disease course in females, whereas it exacerbates it in males.

Authors:  Antonio J Jimenez-Caliani; Silvia Jimenez-Jorge; Patrocinio Molinero; Jose M Fernandez-Santos; Ines Martin-Lacave; Amalia Rubio; Juan M Guerrero; Carmen Osuna
Journal:  Endocrinology       Date:  2005-12-22       Impact factor: 4.736

2.  Beneficial pleiotropic actions of melatonin in an experimental model of septic shock in mice: regulation of pro-/anti-inflammatory cytokine network, protection against oxidative damage and anti-apoptotic effects.

Authors:  Antonio Carrillo-Vico; Patricia J Lardone; Latifa Naji; José M Fernández-Santos; Inés Martín-Lacave; Juan M Guerrero; Juan R Calvo
Journal:  J Pineal Res       Date:  2005-11       Impact factor: 13.007

3.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus.

Authors:  M C Hochberg
Journal:  Arthritis Rheum       Date:  1997-09

4.  Plasma melatonin concentration before and during testosterone replacement in Klinefelter's syndrome: relation to hepatic indolamine metabolism and sympathoadrenal activity.

Authors:  S Caglayan; M Ozata; G Ozisik; M Turan; E Bolu; C Oktenli; N Arslan; K Erbil; D Gul; I C Ozdemir
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

Review 5.  The contribution of extrapineal sites of melatonin synthesis to circulating melatonin levels in higher vertebrates.

Authors:  G Huether
Journal:  Experientia       Date:  1993-08-15

Review 6.  Melatonin: reducing molecular pathology and dysfunction due to free radicals and associated reactants.

Authors:  Russel J Reiter; Duan-Xian Tan; Mario Allegra
Journal:  Neuro Endocrinol Lett       Date:  2002-04       Impact factor: 0.765

7.  A teratocarcinoma developing after gross total excision of a pineal teratoma in a patient with systemic lupus erythematosus.

Authors:  A Shah; B Sadasivan; B M Leng; J Ho
Journal:  Neurol Res       Date:  1995-06       Impact factor: 2.448

8.  Alterations in circadian rhythms of melatonin and cortisol in patients with bronchial asthma.

Authors:  Guang-he Fei; Rong-yu Liu; Zhi-hong Zhang; Jiang-ning Zhou
Journal:  Acta Pharmacol Sin       Date:  2004-05       Impact factor: 6.150

9.  Melatonin secretion and non-specific immune responses are differentially expressed in corticotropin-dependent and corticotropin-independent Cushing's syndrome.

Authors:  Analia Tomova; Philip Kumanov; Ralitsa Robeva; Stefan Manchev; Rossitza Konakchieva
Journal:  Med Sci Monit       Date:  2008-06

Review 10.  The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus.

Authors:  D Gladman; E Ginzler; C Goldsmith; P Fortin; M Liang; M Urowitz; P Bacon; S Bombardieri; J Hanly; E Hay; D Isenberg; J Jones; K Kalunian; P Maddison; O Nived; M Petri; M Richter; J Sanchez-Guerrero; M Snaith; G Sturfelt; D Symmons; A Zoma
Journal:  Arthritis Rheum       Date:  1996-03
View more
  9 in total

1.  Daily melatonin levels in women with systemic lupus erythematosus.

Authors:  Mehmet Ağıllı; İbrahim Aydın; Fevzi Nuri Aydın
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

Review 2.  The role of melatonin in Multiple Sclerosis.

Authors:  Charalampos Skarlis; Maria Anagnostouli
Journal:  Neurol Sci       Date:  2019-12-16       Impact factor: 3.307

3.  Darkness hormone or daylight hormone in women with systemic lupus erythematosus?

Authors:  Melek Bilgin; Adem Keskin; Recai Aci; Hatice Sule Baklacioglu; Mukadder Arslanbek Erdem
Journal:  Clin Rheumatol       Date:  2022-09-20       Impact factor: 3.650

4.  Causal Relationship Between Sleep Traits and Risk of Systemic Lupus Erythematosus: A Two-Sample Mendelian Randomization Study.

Authors:  Ni Sang; Rui-Chen Gao; Meng-Yao Zhang; Zhen-Zhen Wu; Zhen-Gang Wu; Guo-Cui Wu
Journal:  Front Immunol       Date:  2022-06-17       Impact factor: 8.786

5.  Plasma melatonin levels do not differ in SLE patients.

Authors:  P Wang; H-M Li; Y-F Zou; J-H Tao; H-F Pan
Journal:  Z Rheumatol       Date:  2018-02       Impact factor: 1.372

6.  Association of Melatonin Pathway Gene's Single-Nucleotide Polymorphisms with Systemic Lupus Erythematosus in a Chinese Population.

Authors:  Peng Wang; Lei Liu; Li-Fang Zhao; Chan-Na Zhao; Yan-Mei Mao; Yi-Lin Dan; Qian Wu; Xiao-Mei Li; De-Guang Wang; Hai-Feng Pan
Journal:  J Immunol Res       Date:  2019-11-13       Impact factor: 4.818

7.  Melatonin exerts immunoregulatory effects by balancing peripheral effector and regulatory T helper cells in myasthenia gravis.

Authors:  Ting Chang; Chunxiao Niu; Chao Sun; Ying Ma; Rongjing Guo; Zhe Ruan; Yanwu Gao; Xiaodan Lu; Huanhuan Li; Ye Lin; Jiaji Lin; Zhuyi Li
Journal:  Aging (Albany NY)       Date:  2020-11-02       Impact factor: 5.682

8.  A Survey on Sleep Disorders and Related Hormones in Patients with Newly Diagnosed Systemic Lupus Erythematosus.

Authors:  Maryam Sahebari; Sahar Ravanshad; Yalda Ravanshad; Fariborz Rezaeitalab; Houshang Rafat Panah Bayegi; Hadi Asadpour; Seyed Alireza Javadinia; Zahra Rezaieyazdi
Journal:  Mediterr J Rheumatol       Date:  2021-06-30

9.  Immunomodulation by classical conditioning in NZB/W (F1) mice: Lifespan and diurnal variation.

Authors:  Mario André Leocadio Miguel; Luiz Menna-Barreto
Journal:  Sleep Sci       Date:  2016-01-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.